Aehr Test Systems vs Becton Dickinson and Co — how do they compare? Aehr Test Systems trades at $123 (market cap $3.82B), while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 12.9× Aehr Test Systems's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Aehr Test Systems pays none. Which is the better fit depends on your goals.
| AEHR | BDX | |
|---|---|---|
Market Cap | $3.82B | $49.41B |
Sector | Technology | Health |
52-Week High | $117.18 | $185.39 |
52-Week Low | $17.38 | $138.62 |
Enterprise Value | $3.72B | $65.51B |
Dividend Yield | — | 2.32% |
Trailing returns across standard periods
Latest headlines on both assets
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →